1The Diabetic Retinopathy Study Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of diabetic retinopathy study (DRS)findings, DRS report8. Ophthalmology, 1981,88 : 582-600.
2Early Treatment Diabetic Retinopathy Study Group. Photocoagulation for diabetic macular edema: ETDRS report number 1. Arch Ophthalmol,1985,103:1796-1806.
3Meyer-Schwickerath GR. The history of photocoagulation. Aust N Z J Ophthalmol, 1989, 17:427-434.
4Tso MOM. Retinal photocoagulation therapy: Clinical application and biological basis of therapeutic effects// Tso MOM. Retinal Disease. Philadelphia:Philadelphia J B Lippincott Company, 1988:247-250.
5The Krypton Argon Regression Neovascularization Study report number 1. Randomized comparison of krypton versus argon scatter photocoagulation for diabetic disc neovascularization. Ophthalmology, 1993, 100: 1655-1664.
6Early Treatment Diabetic Retinopathy Study Group. Grading diabetic retinopathy from stereoscopic color fundus photographs -An extension of the modified Airlie House Classification. ETDRS report number10. Ophthalmology, 1991,98 : 786-806.
8Reddy VM, Zamora RL, Olk RJ. Quantitation of retinal ablation in proliferative diabetic retinopathy. Am J Ophthalmol, 1995,119:760-766.
9Roider J. Laser treatment of retinal diseases by subthreshold laser effects. SeminOphthalmol,1999,14:19-26.
10Early Treatment Diabetic Retinopathy Study Group. Early photocoagulation for diabetic retinopathy: ETDRS report number 9. Ophthalmology, 1991, 98: 766-785.
